Related Experiment Video
Updated: Jan 23, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Insights
Budd-Chiari syndrome can lead to liver cirrhosis, requiring anticoagulation with dabigatran. Idarucizumab, a dabigatran antidote, is crucial for managing coagulation during liver transplantation in these patients.
Area of Science:
- Hepatology
- Transplant Surgery
- Hematology
Background:
- Budd-Chiari syndrome is a serious hepatic vascular condition.
- Chronic Budd-Chiari syndrome can progress to liver cirrhosis.
- Anticoagulant therapy, including dabigatran, is indicated for Budd-Chiari syndrome.
Observation:
- Advanced liver cirrhosis may necessitate liver transplantation.
- Dabigatran is an anticoagulant used in managing Budd-Chiari syndrome.
- Idarucizumab serves as a specific antidote for dabigatran.
Findings:
- The case report details the first use of idarucizumab in a liver transplant patient with Budd-Chiari syndrome.
- Idarucizumab facilitates coagulation adjustment and bleeding risk management.
- This highlights the clinical utility of idarucizumab in complex transplant scenarios.
Implications:
- Idarucizumab is a valuable tool for managing patients on dabigatran undergoing liver transplantation.
- This approach can improve outcomes for Budd-Chiari syndrome patients requiring liver transplants.
- Further research into idarucizumab use in liver transplantation is warranted.
Abstract:
Budd-Chiari syndrome is a serious condition which in chronic course leads to the development of liver cirrhosis. Anti-coagulant treatment of this syndrome is fully indicated and in the treatment can be used dabigatran. Advanced cirrhosis of the liver due to this disease can be an indication for a liver transplant. In this case, it is a great advantage the existence of an antidote to dabigatran (idarucizumab) in order to adjust the coagulation ratios and prevent bleeding disorders. Referred to a case report describes the first experience with idarucizumab in context with liver transplant in a patient with Budd-Chiari syndrome.
More Related Videos
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
11:50Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
Related Concept Videos
Data Reporting and Recording
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...
Theoretical Foundations of Nursing Practice
Theories provide a perspective to assess patients' conditions and organize data and methods. They also assist in analyzing and interpreting information. They represent a...
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Equivalent Circuits for Practical Transformers
In a practical transformer, each winding exhibits resistance and leakage reactance. The...